Premise: Amdoxovir is a nucleoside reverse transcriptase inhibitor (NRTI) undergoing research for the treatment of HIV/AIDS. It was discovered by Raymond F. Schinazi (Emory University) and C.K. Chu (University of Georgia). It is being developed by RFS Pharma. Currently, it is in Phase II clinical studies.
Hypothesis: Raymond F. Schinazi is affiliated with Emory University